Maarten Kraan

Maarten Kraan

Company: AM-Pharma

Job title: Chief Medical Officer


Navigating Phase 3 Clinical Trials for Sepsis-Associated Acute Kidney Injury to Break the Mould in AKI 2:30 pm

From identifying patients to defining endpoints: analyzing a 650-patient phase 3 trial in AKI Surmounting 28-day mortality data and composite endpoints Redefining a new path to approval: what does the future of AKI drug development look like?Read more

day: Seminar Day

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.